Holen Sie sich die Stockscreener-App
13.73
1.15%
-0.16
Finanzdaten der Theravance Biopharma Inc-Aktie (TBPH)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
29.91%
19.99
|
15.39 | 18.75 | 16.87 | 14.26 |
Operating Expenses
|
11.32%
26.45
|
29.82 | 27.95 | 27.70 | 29.96 |
| Benefits Costs and Expenses |
22.51%
22.88
|
29.53 | - | - | - |
| Costs And Expenses |
22.51%
22.88
|
29.53 | 27.95 | 27.70 | 29.96 |
| Operating Income/Loss |
55.28%
-6.455
|
-14.43 | -9.20 | -10.84 | -15.71 |
| Income/Loss From Continuing Operations Before Tax |
79.57%
-2.889
|
-14.14 | 18.75 | -10.05 | -15.22 |
| Income Tax Expense/Benefit |
1,064%
-6.504
|
-0.559 | 6.588 | 2.646 | 1.308 |
| Income/Loss From Continuing Operations After Tax |
126.62%
3.615
|
-13.58 | -15.53 | -12.70 | -16.53 |
|
Net Income/Loss
|
126.62%
3.615
|
-13.58 | -15.53 | -12.70 | -16.53 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.64%
50.52
|
49.71 | 0.157 | 49.04 | 48.75 |
| Diluted Average Shares |
4.43%
51.91
|
49.71 | 0.157 | 49.04 | 48.75 |
| Basic Earnings Per Share |
125.93%
0.07
|
-0.27 | -0.31 | -0.26 | -0.34 |
| Diluted Earnings Per Share |
125.93%
0.07
|
-0.27 | -0.31 | -0.26 | -0.34 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):